In another large study of adults with type 2 diabetes (aged 50-75 years), subjects were randomly treated with either the cholesterol and triglyceride lowering drug fenofibrate (Tricor) (200 mg/day
Treatment should complement rather than replace lifestyle modifications, with multidisciplinary support including dietetic input, psychological support, and regular medical monitoring essential for optimal outcomes
Weight loss of 510% total body weight can improve physical function and such cardiometabolic risk factors as blood pressure and lipid profile, whilst weight loss exceeding 10% can additionally improve cancer risk, fertility, and health-care costs, while further improving cardiometabolic outcomes [43, 44]
Together, the cumulative cardiovascular strain increases risk of tachycardia, atrial arrhythmias, and hypertensive episodesparticularly in patients with pre-existing heart disease or borderline blood pressure control
The rationale is straightforward: tirzepatide activates GIP receptors that liraglutide does not touch, so your body needs time to adjust to the new mechanism
PlexusDx supports this precision-wellness approach by helping patients and providers understand which metabolic and genetic factors may influence medication selection and tolerance